Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
European Journal of Immunology
|
October 18, 2019
High-throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells
Paul Tuijnenburg, Daan J Aan de Kerk, Machiel H Jansen, et al.
Nucleic Acids Research
|
July 2, 2024
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
Ruben Schep, Max Trauernicht, Xabier Vergara, et al.
The Journal of Experimental Medicine
|
November 30, 2018
Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities
Michela Serresi, Bjorn Siteur, Danielle Hulsman, et al.
Nature Communications
|
June 22, 2024
Widespread chromatin context-dependencies of DNA double-strand break repair proteins
Xabier Vergara, Anna G Manjón, Marcel de Haas, et al.
Cell Reports
|
October 19, 2017
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
Liqin Wang, Rodrigo Leite de Oliveira, Cun Wang, et al.
Cancers
|
December 24, 2021
Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer
Isabel Mayayo-Peralta, Beatrice Faggion, Liesbeth Hoekman, et al.
Oncotarget
|
November 2, 2017
Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity
Amy J C Dohmen, Xiaohang Qiao, Anja Duursma, et al.
Genome Biology
|
December 31, 2024
Molecular dependencies and genomic consequences of a global DNA damage tolerance defect
Daniel de Groot, Aldo Spanjaard, Ronak Shah, et al.
Life Science Alliance
|
May 9, 2022
Genetic and compound screens uncover factors modulating cancer cell response to indisulam
Ziva Pogacar, Kelvin Groot, Fleur Jochems, et al.
Molecular Cell
|
April 13, 2021
Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance
Ruben Schep, Eva K Brinkman, Christ Leemans, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
European Journal of Immunology
|
October 18, 2019
High-throughput compound screen reveals mTOR inhibitors as potential therapeutics to reduce (auto)antibody production by human plasma cells
Paul Tuijnenburg, Daan J Aan de Kerk, Machiel H Jansen, et al.
Nucleic Acids Research
|
July 2, 2024
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
Ruben Schep, Max Trauernicht, Xabier Vergara, et al.
The Journal of Experimental Medicine
|
November 30, 2018
Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities
Michela Serresi, Bjorn Siteur, Danielle Hulsman, et al.
Nature Communications
|
June 22, 2024
Widespread chromatin context-dependencies of DNA double-strand break repair proteins
Xabier Vergara, Anna G Manjón, Marcel de Haas, et al.
Cell Reports
|
October 19, 2017
High-Throughput Functional Genetic and Compound Screens Identify Targets for Senescence Induction in Cancer
Liqin Wang, Rodrigo Leite de Oliveira, Cun Wang, et al.
Cancers
|
December 24, 2021
Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer
Isabel Mayayo-Peralta, Beatrice Faggion, Liesbeth Hoekman, et al.
Oncotarget
|
November 2, 2017
Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity
Amy J C Dohmen, Xiaohang Qiao, Anja Duursma, et al.
Genome Biology
|
December 31, 2024
Molecular dependencies and genomic consequences of a global DNA damage tolerance defect
Daniel de Groot, Aldo Spanjaard, Ronak Shah, et al.
Life Science Alliance
|
May 9, 2022
Genetic and compound screens uncover factors modulating cancer cell response to indisulam
Ziva Pogacar, Kelvin Groot, Fleur Jochems, et al.
Molecular Cell
|
April 13, 2021
Impact of chromatin context on Cas9-induced DNA double-strand break repair pathway balance
Ruben Schep, Eva K Brinkman, Christ Leemans, et al.
Page
of 4